Manacquit, Jenevie S.
HRN: 24-57-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2024
CEFTRIAXONE 1G (VIAL)
02/13/2024
02/19/2024
IV
2g
Q24
T/C Bacterial Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes